Clinical Research Directory
Browse clinical research sites, groups, and studies.
TDM Guided Early Optimization of ADAL in Crohn's Disease
Sponsor: waqqas.afif
Summary
To investigate the influence of early therapeutic drug monitoring and dose optimization on disease outcome in Crohn's patients treated with Adalimumab.
Official title: Therapeutic Drug Monitoring Guided Early Optimization of Adalimumab in Crohn's Disease; A Randomized Open Label Study
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
200
Start Date
2017-01-17
Completion Date
2025-06-01
Last Updated
2025-05-25
Healthy Volunteers
No
Interventions
Adalimumab
Locations (6)
University of Calgary Medical Center (UCMC)
Calgary, Alberta, Canada
The University of British Columbia
Vancouver, British Columbia, Canada
London Health Sciences Centre (LHSC) University Hospital
London, Ontario, Canada
The Ottawa Hospital, IBD Centre of Excellence
Ottawa, Ontario, Canada
McGill University Hospital Center (MUHC)
Montreal, Quebec, Canada
Centre Hospitalier Universitaire de Sherbrooke (CHUS)
Sherbrooke, Quebec, Canada